- Sugden BW, Katchmar R. Bioterrorism and its aftermath: dealing individually and organizationally
with the emotional reactions to an anthrax attack. Int J Emerg Ment Health 2005; 7:203–211. - Wong SS, Yuen KY. Avian influenza virus infections in humans. Chest 2006; 129:156–168.
- Sugrue RJ, Tan BH, Yeo DS, et al. Antiviral drugs for the control of pandemic influenza virus. Ann
Acad Med Singapore 2008; 37:518–524. - Wang L-F, Shi Z, Zhang S, et al. Review of bats and SARS. Emerg Infect Dis 2006; 12:1834–1840.
- Hui DS, Chan PK. Clinical features, pathogenesis and immunobiology of severe acute respiratory
syndrome. Curr Opin Pulm Med 2008; 14:241–247. - Lam CW, Chan MH, Wong CK. Severe acute respiratory syndrome: clinical and laboratory
manifestations. Clin Biochem Rev 2004; 25:121–132. - McDonald LC, Simor AE, Su IJ, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect
Dis 2004; 10:777–781. - Levy MM, Baylor MS, Bernard GR, et al. Clinical issues and research in respiratory failure from
severe acute respiratory syndrome. Am J Respir Crit Care Med 2005; 171:518–528 - Dowell SF, Ho MS. Seasonality of infectious diseases and severe acute respiratory syndrome—what
we don’t know can hurt us. Lancet Infect Dis 2004; 4:704–708. - Tang F, Liu W, Zhang F, et al. IL-12 RB1 genetic variants contribute to human susceptibility to severe
acute respiratory syndrome infection among Chinese. PLoS ONE 2008; 3:e2183. - Srikantiah P, Charles MD, Reagan S, et al. SARS clinical features, United States, 2003. Emerg Infect
Dis 2005; 11:135–138. - Stockman LJ, Masssoudi MS, Helfand R, et al. Severe acute respiratory syndrome in children. Pediatr
Infect Dis J 2007; 26:68–74. - Yam LY, Chen RC, Zhong NS. SARS: ventilatory and intensive care. Respirology 2003;
8(suppl):S31–S35. - Richardson SE, Tellier R, Mahony J. The laboratory diagnosis of severe acute respiratory syndrome:
emerging laboratory tests for an emerging pathogen. Clin Biochem Rev 2004; 25:133–142. - Kinjo K, Terabe H, Ogawa M, et al. A case of catastrophic antiphospholipid syndrome presenting
with acute respiratory distress syndrome as the initial manifestation. Rheumatol Int 2008;
29:211–216. - Centers for Disease Control and Prevention (CDC). Acute respiratory distress syndrome in persons
with tickborne relapsing fever—three states, 2004–2005. MMWR Morb Mortal Wkly Rep 2007;
56:1073–1076. - Phua GC, Govert J. Mechanical ventilation in an airborne epidemic. Clin Chest Med 2008;
29:323–328, vii. - Kao HK, Wang JH, Sung CS, et al. Pneumothorax and mortality in the mechanically ventilated SARS
patients: a prospective clinical study. Crit Care 2005; 9:R440–R445. - Monath TP. Treatment of yellow fever. Antiviral Res 2008; 78:116–124.
- Cleri DJ, Hamid NS, Panesar M, et al. Rabies (Part I and Part II). Infect Dis Prac Clin 2004; 28:303–308,
315–318. - Dutta JK, Dutta TK, Das AK. Human rabies: modes of transmission. J Assoc Phys India 1992;
40:322–324. - Centers for Disease Control and Prevention (CDC). Human rabies—Alberta, Canada, 2007. MMWR
Morb Mortal Wkly Rep 2008; 57(8):197–200. - Hemachudha T, Wilde H, Willoughby RE Jr, et al. Survival after treatment of rabies. N Engl J Med
2005; 353:1068. - Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of
coma. N Engl J Med 2005; 352:2508–2514. - Hemachudha T, Sunsaneewitayakul B, Desudchit T, et al. Failure of therapeutic coma and ketamine
for therapy of human rabies. J Neurovirol 2006; 12:407–409. - Jackson AC, Scott CA, Owen J, et al. Human rabies therapy: lessons learned from experimental
studies in mouse models. Dev Biol (Basel) 2008; 131:377–385. - Willoughby RE, Roy-Burman A, Martin KW, et al. Generalized cranial artery spasm in human
rabies. Dev Biol (Basel) 2008; 131:367–375.
486 Cleri et al.